Impact of Community Palliative Care on Quality of Life among Cancer Patients in Bangladesh

• Published in: International journal of environmental research and public health 2023-07, Vol.20 (15), p.6443
• Main Authors: Chowdhury, Mostofa Kamal, Saikot, Shafiquejjaman, Farheen, Nadia, Ahmad, Nezamuddin, Alam, Sarwar, Connor, Stephen R
• Format: Article
• Language: English
• Subjects: Cancer therapies; Caregivers; Collaboration; Costs; Health care policy; Oncology; Palliative care; Patients; Primary care; Quality of life; Symptom management
• ISSN: 1660-4601; 1661-7827; 1660-4601
• DOI: 10.3390/ijerph20156443

Cancer, a leading cause of mortality worldwide, is often diagnosed at late stages in low- and middle-income countries, resulting in preventable suffering. When added to standard oncological care, palliative care may improve the quality of life (QOL) of these patients. A longitudinal observational study was conducted from January 2020 to December 2021. Thirty-nine cancer patients were enrolled in the Compassionate Narayanganj community palliative care group (NPC), where they received comprehensive palliative care in addition to oncological care. Thirty-one patients from the Dept. of Oncology (DO) at BSMMU received standard oncological care. In contrast to the DO group, the NPC group had a higher percentage of female patients, was older, and had slightly higher levels of education. At 10 to 14 weeks follow-up, a significant improvement in overall QOL was observed in the NPC group ( = 0.007), as well as in the psychological ( = 0.003), social ( = 0.002), and environmental domains ( = 0.15). Among the secondary outcomes, the palliative care group had reduced disability and neuropathic pain scores. Additionally, there were statistically significant reductions in pain, drowsiness, and shortness of breath, as well as an improvement in general wellbeing, based on the results of the Edmonton Symptom Assessment Scale-Revised. At the community level in Bangladesh, increased access to palliative care may improve cancer patient outcomes such as QOL and symptom burden.